NCT01866176

Brief Summary

The purpose of this study is to evaluate the immediate effects of a knee brace with a new mechanism on the pain and medial knee loading during gait among medial knee osteoarthritis patients. The effects of this new brace is compared to a stabilizing brace and a typical valgus knee brace. The investigators recruited 24 knee osteoarthritis and they have to wear each of the three braces during three months. A fifteen days wash-out period is given after each three months. Biomechanical evaluation is carried out before and after each three months. This evaluation consisted of three questionnaires (KOOS, WOMAC and Medical Outcome Score Short Form-36 (MOS-SF36)), a motion analysis with an optoelectronic system, then a 6-min walk test. During motion analysis, ten gait trials are executed without brace and ten with the brace.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable knee-osteoarthritis

Timeline
Completed

Started Oct 2011

Typical duration for not_applicable knee-osteoarthritis

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2011

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2013

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

May 9, 2013

Completed
22 days until next milestone

First Posted

Study publicly available on registry

May 31, 2013

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2013

Completed
Last Updated

March 6, 2014

Status Verified

March 1, 2014

Enrollment Period

1.6 years

First QC Date

May 9, 2013

Last Update Submit

March 5, 2014

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in Knee adduction moment

    Change from Baseline at 3 months

  • Change in Knee pain

    A 20-cm visual analog scale (0-100) is used to assess pain.

    Change from Baseline at 3 months

Secondary Outcomes (4)

  • Change in Spatiotemporal gait parameters

    Change from Baseline at 3 months

  • Change in Gait velocity

    Change from Baseline at 3 months

  • Change in Knee adduction angle

    Change from Baseline at 3 months

  • Change in Knee brace comfort

    Change from Baseline at 3 months

Study Arms (1)

Knee osteoarthritis patients

EXPERIMENTAL

Knee osteoarthritis patients with Kellgren \& Lawrence grade I, II or III Stabilizing Knee Brace Valgus Knee Brace New Knee Brace

Device: Stabilizing Knee BraceDevice: Valgus Knee BraceDevice: New Knee Brace

Interventions

Brace with no valgus action

Knee osteoarthritis patients

Valgus brace with traditional three point bending system

Knee osteoarthritis patients

Brace with new mechanism to decrease the knee loading.

Knee osteoarthritis patients

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Symptomatic medial knee OA (Kellgren-Lawrence grade I, II or III) according to clinical and radiological criteria of the American College of Rheumatology
  • Knee pain \> 31/100 (Western Ontario and McMaster Universities Arthritis Index - WOMAC)
  • Moderately active
  • Varus knee alignment equal or superior to 2°

You may not qualify if:

  • Severe knee OA (K-L grade IV)
  • Rheumatoid arthritis or other inflammatory arthritis
  • Avascular necrosis
  • History of periarticular fracture or septic arthritis
  • Bone metabolic disease
  • Pigmented villonodular synovitis
  • Cartilaginous disease
  • Neuropathic arthropathy
  • Synovial osteochondromatosis
  • Total or partial knee arthroplasty
  • Flexion contracture of ipsi- or contra-lateral knee greater than 15°
  • Hip or ankle joint damage with mobility limitation
  • Obesity (BMI ≥ 40)
  • Intra-articular corticosteroids injection in the affected knee during the two previous months
  • Reduced mobility (Charnley class C)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pavillon de l'Éducation Physique et des Sports - Université Laval

Québec, Quebec, G1V 0A6, Canada

Location

MeSH Terms

Conditions

Osteoarthritis, Knee

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • Philippe Corbeil, PhD

    Laval University

    STUDY DIRECTOR
  • Yoann Dessery, MSc

    Laval University

    PRINCIPAL INVESTIGATOR
  • Étienne L Belzile, MD

    Laval University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 9, 2013

First Posted

May 31, 2013

Study Start

October 1, 2011

Primary Completion

May 1, 2013

Study Completion

August 1, 2013

Last Updated

March 6, 2014

Record last verified: 2014-03

Locations